The trial demonstrated a statistically significant difference in serum phosphorus levels for the tenapanor group over the placebo group.
Keryx Biopharmaceuticals announced an interruption will occur in the supply of Auryxia (ferric citrate) tablets due to a production-related issue.
For patients with end-stage renal disease (ESRD), daily cocoa flavanol (CF) ingestion alleviates acute and chronic hemodialysis (HD)-induced vascular dysfunction, according to a study published online in the Clinical Journal of the American Society of Nephrology.
Keryx announced the launch of Auryxia (ferric citrate) tablets to control serum phosphorous levels in patients with chronic kidney disease (CKD) on dialysis.
Keryx Biopharmaceuticals announced that the Food and Drug Administration (FDA) has approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
A New Drug Application (NDA) was submitted to the FDA for Zerenex (ferric citrate coordination complex) for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.